Skip to content 
Search

Latest Stories

Doctors warn of new covid symptom as nimbus variant spreads across the UK

Doctors have identified a distinctive new symptom: A razor blade sore throat

What Makes the 'Nimbus' Covid Variant Symptoms Different?

Experts warn that nimbus may be more efficient at infecting human cells than earlier variants

iStock

A new covid variant, known as nimbus (scientifically NB.1.8.1), is causing concern among health experts as cases rise globally. The variant, a descendant of omicron, has been detected in several countries, including China, Singapore, Hong Kong, and the UK. While its symptoms are largely similar to previous covid strains, doctors have identified a distinctive new symptom: a razor blade sore throat, characterised by an intense stabbing pain when swallowing.

Experts warn that nimbus may be more efficient at infecting human cells than earlier variants, which could lead to increased transmission rates. Although there is no current evidence to suggest that it causes more severe illness than its predecessors, the rapid spread has raised concerns, particularly among vulnerable groups.


Symptoms of nimbus

Like previous Covid variants, nimbus presents with a range of symptoms, including fever, muscle aches, congestion, and shortness of breath. However, one symptom, in particular, is capturing attention—the razor blade sore throat. This sensation, described by medical experts as a sharp, stabbing pain at the back of the throat, makes swallowing extremely uncomfortable.

Other symptoms include redness in the throat, swollen neck glands, and general discomfort when eating or drinking. Some patients have also reported experiencing fatigue, headaches, and a persistent cough. While these symptoms may overlap with those of earlier variants, doctors emphasise that the severity and persistence of the sore throat are unique to nimbus.

Spread and concerns

Although only a small number of cases have officially been recorded in the UK, experts believe the actual spread of nimbus could be significantly wider. This is due to the decline in routine Covid testing since the height of the pandemic. According to UK Health Security Agency (UKHSA) data, the number of people testing positive for Covid has increased significantly in recent months. Reports indicate that infection rates have surged by 97% compared to figures recorded earlier in the year.

Virologists are warning that the number of Covid cases could continue to rise, particularly as summer approaches. Increased social interaction, crowded events, and holiday travel all create conditions for virus transmission. Professor Lawrence Young, a virologist at Warwick University, notes that while many respiratory viruses, such as flu, tend to subside in warmer climates, Covid continues to spread even in hot and humid weather. This makes it difficult to predict the scale of a possible summer wave.

Another concerning aspect is that population immunity, whether from vaccination or prior infection, appears to be waning over time. This means that even those who have had previous covid infections or vaccinations may still be at risk of catching nimbus.

Severity and vaccination

Laboratory studies suggest that nimbus is capable of infecting human cells more efficiently than previous strains. While there is no evidence indicating that it leads to more severe illness or higher fatality rates than earlier Covid variants, doctors stress that infection can still be dangerous for vulnerable individuals.

In May alone, Covid was a contributing factor in the deaths of over 300 people in England. The elderly, individuals with weakened immune systems, and those with pre-existing medical conditions remain particularly at risk.

 What Makes the 'Nimbus' Covid Variant Symptoms Different? The UKHSA is closely monitoring its progression and is assessing its impact on public healthiStock

Vaccination continues to be the strongest defence against severe illness. Experts say that current Covid vaccines, reformulated to target omicron-related variants, are expected to offer protection against nimbus. Research indicates that individuals who received a Covid booster jab as part of last spring’s vaccination campaign were 45% less likely to require hospital care following infection, compared to those who had not been vaccinated.

Global outlook

According to the World Health Organisation (WHO), nimbus now accounts for 10.7% of global Covid cases, a sharp increase from just 2.5% a month earlier. The UKHSA is closely monitoring its progression and is assessing its impact on public health.

Dr Gayatri Amirthalingam, deputy director of the UKHSA, has stated that the organisation is keeping track of all available data related to Covid variants in the UK and abroad. While nimbus has only been detected in small numbers in the UK so far, international data indicates that it is growing as a proportion of all Covid cases worldwide.

Preventative measures and vaccination eligibility

Health authorities continue to urge eligible individuals to receive their Covid vaccinations. In the UK, free vaccines are available for specific groups, including people aged 75 and older, care home residents, and those with weakened immune systems. This includes patients undergoing cancer treatment, organ transplant recipients, and individuals with genetic disorders that affect the immune system.

Getting vaccinated remains essential in protecting against severe illness and hospitalisation. While nimbus may not be more lethal than previous variants, experts emphasise that its ability to infect cells efficiently makes it highly transmissible. Vigilance, personal hygiene, and vaccination all play crucial roles in reducing the risk of infection.

The spread

The emergence of the nimbus variant is a stark reminder that Covid continues to evolve. While symptoms are similar to previous strains, the distinct razor blade sore throat is emerging as a defining characteristic of the latest variant. Experts warn that its ability to spread efficiently could lead to a summer surge in cases, particularly as population immunity declines.

Although there is no evidence that nimbus causes more severe illness than past variants, it remains a threat to vulnerable individuals. Health officials continue to recommend vaccination as the best means of protection. With the UKHSA closely monitoring its spread, staying informed and maintaining caution remain essential as the situation develops.

More For You

Samaritans branch closures

Samaritans currently has 22,000 listening volunteers

Alamy

Samaritans to shut 100+ branches in UK and Ireland under major restructure

Highlights

  • Samaritans plans to close at least half of its 200 branches over the next 7–10 years
  • Volunteers to be moved into larger regional hubs and remote call handling to be piloted
  • Charity says model is unsustainable; changes aim to increase volunteer flexibility and service capacity
  • Some volunteers express concern over the loss of smaller branch camaraderie and safe spaces
  • Final decision expected in September following consultation

Mental health charity plans shift to larger hubs and remote volunteering

Samaritans has announced plans to close at least 100 of its 201 branches across the UK and Ireland in the next seven to ten years, as part of a major restructuring strategy aimed at improving service delivery and reducing infrastructure costs.

The charity, which operates a 24/7 mental health helpline, says it intends to move volunteers into larger regional centres and trial a remote volunteering model. The shift is intended to provide greater flexibility, increase the number of volunteers on shift at any time, and reduce spending on building maintenance.

Keep ReadingShow less
Mounjaro side effects

Social media has recently drawn attention to the psychological challenges

iStock

The silent emotional side effect of Mounjaro jabs users are just beginning to talk about

Highlights

  • Mounjaro (tirzepatide) is a diabetes drug also prescribed for weight loss
  • Users report emotional side effects, including low motivation and feeling “stuck”
  • A TikTok post describing the “slow middle” of weight loss struck a chord with others
  • The injection can support weight loss of up to 20% over a year
  • Drug is now sold in UK supermarkets including Tesco and Morrisons


While Mounjaro has become increasingly popular for aiding weight loss, users have begun highlighting a less-discussed side effect — an emotional downturn midway through treatment.

The medication, also known by its generic name tirzepatide, is a weekly injection originally developed to manage type 2 diabetes. It has since gained traction for its weight loss benefits, with some patients shedding up to 20% of their body weight over the course of a year.

Keep ReadingShow less
HPV vaccine 16 to 25

Many of those targeted missed their vaccine during school years

iStock

NHS steps up HPV vaccine rollout for young people aged 16–25

Highlights

  • NHS encourages unvaccinated people aged 16–25 to get the HPV vaccine
  • Over 418,000 school leavers in past three years missed vaccination
  • HPV vaccine protects against cervical and other related cancers
  • NHS aiming for 90% uptake among girls by 2040
  • Letters, emails, texts and NHS App alerts being used for reminders

NHS campaign targets unvaccinated young adults

The NHS is urging hundreds of thousands of young people aged 16 to 25 to come forward for the HPV vaccine, which protects against cervical and other types of cancer.

Many of those targeted missed their vaccine during school years. According to NHS England, over 418,000 children left school without receiving the HPV jab in the past three years.

Keep ReadingShow less
Bryan Johnson

He now believes that commercial interests may be at odds with his philosophical mission

Getty Images

Bryan Johnson may shut down anti-ageing startup to focus on religion

Highlights

  • Bryan Johnson, 47, is contemplating shutting down or selling his anti-ageing startup, Blueprint.
  • The biotech entrepreneur recently launched a religion called "Don’t Die."
  • He says commercial activity is undermining his philosophical credibility.
  • Blueprint has faced financial pressures but Johnson denies any crisis.

Biotech entrepreneur and longevity enthusiast Bryan Johnson has revealed he is considering shutting down or selling his anti-ageing company, Blueprint. Speaking to Wired, the 47-year-old said his priorities have shifted towards developing his newly founded religion, "Don’t Die", which he believes better aligns with his philosophical ambitions.

“I am so close to either shutting it down or selling it,” Johnson said in the interview published Monday. “I don’t need the money, and it’s a pain-in-the-ass company.”

Keep ReadingShow less
slimming jab Morrisons

The move has sparked criticism on social media

iStock

Morrisons launches £129-a-month weight loss injection service

Highlights

  • Morrisons Clinic introduces subscription service for tirzepatide injections
  • The treatment may aid weight loss of up to 20% over one year
  • Monthly subscription will increase from £129 to £159 after introductory period
  • Service includes medical assessment and regular check-ins
  • Criticism emerges over the supermarket’s continued sale of unhealthy food


Morrisons has launched an online subscription service offering weight loss injections, prompting mixed reactions from the public. The supermarket’s online health platform, Morrisons Clinic, now offers tirzepatide — also known by the brand name Mounjaro — for weight management.

Tirzepatide is primarily prescribed to treat type 2 diabetes, but has also been approved for weight loss. According to Morrisons Clinic, users may lose up to 20 per cent of their body weight over the course of a year.

Keep ReadingShow less